Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Despite the potential benefits for weight management, Linda and her healthcare provider decided to discontinue GLP-1 medications during her pregnancy, prioritizing the safety of her unborn child
Many patients who could not access insurance coverage or afford out-of-pocket brand-name pricing turned to compounded alternatives offered through telehealth platforms at lower price points
(2024) Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications
The short answer is yesyou can stop at any timebut research shows that weight regain happens in most patients who discontinue the medication without ongoing lifestyle support
However, the data presented here in conjunction with clinical data on this mechanism in ALS suggests that it may not be of value to perform clinical studies with GLP-1 agonists in ALS and that resources may be more usefully focussed elsewhere
